Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine formula for treating prostatitis and benign prostatic hyperplasia and preparation process thereof

A technology for benign prostatic hyperplasia and prostatitis, which is applied in the field of medicine to achieve the effects of short course of treatment, guaranteed safety and less resistance to drug resistance

Pending Publication Date: 2021-11-19
查国章 +4
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, the existing treatment technology can no longer meet people's demand for it.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine formula for treating prostatitis and benign prostatic hyperplasia and preparation process thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0022] A medicinal formula for treating prostatitis and benign prostatic hyperplasia, comprising the following components by weight, cefoperazone sodium sulbactam sodium 1000-8000mg, edetate disodium 2-40mg, dexamethasone 1-20mg, levobupivacaine 20-20mg 200mg, procaine 40 ~ 400mg.

[0023] Preparation:

[0024] (1) Dissolve cefoperazone sodium and sulbactam sodium with an appropriate amount of 0.9% sodium chloride solution for injection, and then dilute to 5-50ml with the same solution. After dissolving cefoperazone sodium, the molar concentration is 0.2mol / L. The concentration is 0.31mol / L

[0025] (2) Then dilute to 5-50ml with the same solution, the molar concentration after dissolving cefoperazone sodium is 0.2mol / L, and the molar concentration after dissolving sulbactam sodium is 0.31mol / L

[0026] Instructions:

[0027] The injection technology of avoiding nerves and blood vessels and inserting needles through the perineal and pelvic space allows the drug to fully pen...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine formula for treating prostatitis and benign prostatic hyperplasia and a preparation process thereof. The medicine formula comprises the following components by weight: 1000 to 8000 mg of cefoperazone sodium sulbactam sodium, 2 to 40 mg of edetate disodium, 1 to 20 mg of dexamethasone, 20 to 200 mg of levobupivacaine, and 40 to 400 mg of procaine. The compatible formula is directly administered through prostate microneedle injection, so that the effects of resisting bacteria, diminishing inflammation and relieving prostatic fibrosis in the prostate body are achieved to the maximum extent, and the formula is suitable for treating various chronic prostatitis and benign prostatic hyperplasia. A large number of clinical cases prove that the formula has the advantages of remarkable curative effect, no pain in treatment, safety, no side effect and the like.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a medicinal formula for treating prostatitis and benign prostatic hyperplasia and a preparation process thereof. Background technique [0002] Chronic prostatitis is a common male disease with high morbidity, intractability and long course, often accompanied by prostatic hyperplasia and prostatic stones, and may cause secondary male infertility and sexual dysfunction, which brings great pain to patients. big pain. Domestic and foreign clinical urology and male specialists have many treatments for diseases such as prostatitis, but they are often incurable and recurrent. Therefore, the existing treatment technology can not meet people's demand for it. [0003] Based on the above reasons, a pharmaceutical formulation for treating prostatitis and benign prostatic hyperplasia has become a technical problem to be solved urgently by those skilled in the art. Contents of the invention [000...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/573A61P13/08A61P31/04A61K31/198A61K31/245A61K31/43A61K31/445A61K31/546
CPCA61K31/546A61K31/445A61K31/198A61K31/573A61K31/245A61K31/43A61P13/08A61P31/04A61K2300/00
Inventor 查国章刘立鹏李江王琼林查宇
Owner 查国章
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products